Transcript Science Fair Project - Federation of American Societies

Breakthroughs in Bioscience
From NIH-Funded Basic Research
to Improved Health
Alabama
National Institutes of Health (NIH)
 Nation’s medical research
agency
 Funds the science that leads to
medical advancement
 Campus in Bethesda, MD – but
most funding is distributed to
university researchers and
physicians throughout the
United States
 With Southern Research Institute,
Birmingham competes successfully for
1% of the NIH budget
UAB’s Research Enterprise Is
Critical to Alabama’s Economy
 Total research funding has doubled every
decade - now about $400 million
 Research supports about 4,000 faculty and
staff and 1,000 trainees with a payroll of
nearly $200 million
 Companies such as Biocryst,
TransMolecular, Vaxin and VectorLogics
are based on UAB technologies
 New initiatives will arise with the $10
million IMPACT set-aside from our state
allocation to hire new faculty
Leveraging the State’s Investment with
Extramural Research Dollars
 For every State dollar invested in UAB, ~$11
returned to Birmingham’s economy
 Research is critical to this leveraging - almost all
from funds coming into the State from external
sources
 A striking example from a clinical division –
Rheumatology
 7% of their budget is from the State
 10% is from clinical income
 83% is from external sources for research
 The primary source of research funding is the
National Institutes of Health
NIH: Saving Lives Through Science
 Current annual budget of around $29.3 billion
 Greater than 80% distributed throughout the country
 More than 50,000 grants
 212,000 scientists
 2,800 universities
 ~ 1%, $194 million comes to Birmingham each year
 Portfolio of basic, translational, and clinical research
NIH has been involved in nearly all the medical & health
related discoveries of the past century
How NIH Makes Science Happen…
 Researchers working at local universities, hospitals and research
institutions are dependent on federal support to fund their research, hire
lab personnel and train young scientists
 They write research grant proposals to compete for funding
 Must explain why they think it’s a good idea, how they’re going to do the
experiments, and what impact it will have on science & medicine
 Proposals are reviewed in a two-tiered system
 Peer-reviewed by scientists to ensure highest quality science
 Reviewed again for applicability to scientific or health priorities by NIH
officials and other stakeholders, including public members
 NIH review system is the envy of the world!
 Very competitive!!!
 Before - 1 in 3 proposals funded; now closer to 1 in 6
 High quality research is not being done for lack of funding
Basic Research: From Bench to Bedside
 Much of NIH funding goes to basic or fundamental research
 Basic research is driven by interest in a scientific question
 The main motivation is to expand knowledge and
understanding, not to create or invent something
 However, the insight into how the human body works and
understanding of how diseases and disorders operate provides
the foundation for medical progress
"People cannot foresee the future well enough to predict
what's going to develop from basic research. If we only did
applied research, we would still be making better spears."
Dr. George Smoot, Berkeley National Lab
What about medical breakthroughs?
 Medical breakthroughs often come from unrelated areas of
science or medicine
 Research on cancer biology has led to drugs for: heart disease;
viral diseases like influenza, Herpes & AIDS; and osteoporosis
 Physicists studying the effects of magnets on atomic particles
made the discovery that gave us MRI
 Usually based on years or decades of fundamental knowledge
 Over time, scientists solve or find different pieces of the puzzle
 This makes it difficult to predict where the next
breakthrough will come from
 Makes it imperative to support a broad range of scientific research
 Much of this research is too basic for the private sector
 The federal investment often lays the foundation for advances in
healthcare
Evolution of Research to
Healthcare
Selected modern examples…
Cardiovascular disease
 Information on the biochemical structure & synthesis
of cholesterol led to the development of statins
 Discoveries in basic kidney biology and blood pressure
regulation converged with an unexpected finding
involving snake venom to yield ACE inhibitors, one of
our most effective hypertension medications
 Understanding how the blood clots, together with a
new cancer treatment and the first commercial use of
recombinant technologies, resulted in rtPA, a clotbusting drug that can prevent death from heart attack
or stroke
RESULTS?? 63% REDUCTION IN DEATHS FROM HEART DISEASE
AND A 70% REDUCTION IN DEATHS DUE TO STROKE; MORE THAN 1
MILLION LIVES SAVED IN 2006 ALONE
Deaths per 100,000
Cardiovascular disease
500
~ 1,329,000
Projected
Deaths in 2000
400
300
200
100
50 55 60 65 70 75 80 85 90 95 00
Year
30-year
Investment per
American
~$110.00 Total
~ 514,000
Actual
Deaths in
2000
Economic return
of improved
treatment &
prevention
$2.6 TRILLION
HIV / AIDS
 Fundamental knowledge of how viruses replicate gave
scientists targets for therapy. Researchers looking for a new
cancer drug hit one of those targets when they discovered a
way to block replication, resulting in the development of
AZT.
 Increased understanding of how HIV operates at the
cellular and molecular level identified more targets, and
eventually led to the combination of drugs knows as the
‘triple cocktail.’
RESULTS?? AIDS HAS BEEN TRANSFORMED FROM AN ACUTE
FATAL ILLNESS TO A CHRONIC CONDITION; THE PROPHYLACTIC
USE OF ANTI-VIRALS PREVENTED ALMOST 350,000 DEATHS
WORLDWIDE IN 2005
HIV / AIDS
Deaths from
AIDS dropped
nearly 70%
between 1995
and 2000
Survival rates for
those infected with
HIV has increased
by 10 years
Cancer
 Basic research into the shape and characteristics of the
estrogen receptor gave us tamoxifen, which can reduce
breast cancer incidence among women at risk by over 45%.
 The breakthrough finding that human papillomavirus
(HPV) could cause cervical cancer has led to a new vaccine
that NIH estimated could reduce cervical cancer incidence
by as much as 90%.
 While investigating the cellular machinery controlling cell
growth, scientists developed bortezomib - now used to treat
patients with multiple myeloma.
RESULTS?? FROM 1993-2002, CANCER DEATH RATES
DROPPED 1.1% PER YEAR; MORE THAN 2/3 OF PEOPLE
DIAGNOSED WITH CANCER CAN EXPECT TO LIVE 5+ YEARS
Cancer
Millions of People
Increase in Cancer Survivors
9
6
3
1971 1986 1990 2003
30-year
Investment per
American
~$260.00 Total
Infant mortality
 Studies on lung function led to the discovery of surfactant.
This protein-lipid mixture is crucial for the survival of
premature infants, decreasing the number of infant deaths
from respiratory distress from 15,000 per year to less than
1,000.
 The use of anti-virals to prevent mother to child HIV
transmission has reduced the rate from 25% to about 1% in
the U.S.
 Studies on a metabolite of progesterone, known as
progesterone 17P, have led to the finding that injections of
this compound can reduce pre-term deliveries by as much as
30%, a particularly important result for African American
women.
RESULTS?? IN LESS THAN A CENTURY, INFANT MORTALITY IN
THE U.S. HAS BEEN REDUCED BY 90%, TRANSLATING TO
ALMOST 500,000 BABIES SAVED PER YEAR
NIH-Funded Discoveries at UAB and
Southern Research Institute
 Studies on nerve cells using a toxin from the Israeli yellow scorpion
led to the discovery of a new treatment for a brain tumor called
glioblastoma, now entering clinical trials
 Work with transgenic mice engineered to express the gene defective
in sickle cell disease has led to a potential cure that is likely less than
five years off
 A new type of white blood cell that is important in autoimmune
diseases was just described
 Drugs that cure viral infections such as those caused by West Nile
virus or SARS are being discovered and tested
 A new understanding of the molecular basis for learning and memory
may lead to better treatments for Alzheimer’s Disease and dementia
 Southern Research has six anti-cancer drugs in clinical trials and six
more poised for evaluation, many of which supported in part by NIH
 Spin-off companies such as Biocryst, TransMolecular, VectorLogics,
and Vaxin are based on discoveries funded by NIH
The Bottom Line…
 People are living longer, healthier lives
because of NIH funded medical research
 What were once swiftly fatal illnesses have
become treatable or manageable conditions
 For those suffering from diseases that have
no current treatment or cure, medical
research provides hope – which has a major
impact on quality of life
The Challenge…
 NIH funding is entirely dependent on Congressional support
 In recent years, Congressional support has diminished, and
the NIH budget is slowly eroding from lack of funding and
inflation
 Lack of understanding in Congress about the importance of
medical research and the treatments and hope it provides
 As the NIH budget falls, UAB’s success rate also falls
Diminished investment in NIH = loss of
talented researchers = missed opportunities
= delays in medical progress
Alabama’s Congressmen Need
to Advocate for NIH Funding
 Nothing should surpass improving our health as a
national priority
 Opportunities for discoveries that translate to
improved health for our citizens have never been
greater
 Every 3% increase in the NIH budget means an
additional $9 million for research in Birmingham and
nearly 100 new jobs
We Need your Help:
Working Together for NIH
 Contact Senators Shelby and Sessions, and
your Congressional Representative
 Let them know that medical research is
important to you and what a bargain it is
 Write a letter to the newspaper and talk to
your friends
 Help educate policymakers and neighbors
about the important work NIH is doing
 Nothing is more important than our health
 The National Institutes of Health (NIH)
should be an American priority
Want to know more??
Please visit
http://opa.faseb.org
Federation of American Societies for Experimental Biology (FASEB)